APA (7th ed.) Citation

Kim, Y., Jeun, M., Lee, H. K., Choi, J. U., Park, S., & Park, C. H. TET2 downregulation enhances the antitumor efficacy of CD19 CAR T cells in a preclinical model. BMC.

Chicago Style (17th ed.) Citation

Kim, Yeongrin, Moonjung Jeun, Heung Kyoung Lee, Ji U. Choi, Simon Park, and Chi Hoon Park. TET2 Downregulation Enhances the Antitumor Efficacy of CD19 CAR T Cells in a Preclinical Model. BMC.

MLA (9th ed.) Citation

Kim, Yeongrin, et al. TET2 Downregulation Enhances the Antitumor Efficacy of CD19 CAR T Cells in a Preclinical Model. BMC.